The right not to know: an autonomy based approach

The emerging international biomedical law tends to recognise the right not to know one’s genetic status. However, the basis and conditions for the exercise of this right remain unclear in domestic laws. In addition to this, such a right has been criticised at the theoretical level as being in contradiction with patient’s autonomy, with doctors’ duty to inform patients, and with solidarity with family members. This happens especially when non-disclosure poses a risk of serious harm to the patient’s relatives who, without that vital information, could be deprived of preventive or therapeutic measures. This paper argues, firstly, that individuals may have a legitimate interest in not knowing their genetic make up to avoid serious psychological consequences; secondly, that this interest, far from being contrary to autonomy, may constitute an enhancement of autonomy; thirdly, that the right not to know cannot be presumed, but must be “activated” by the individual’s explicit choice, and fourthly, that this is not an absolute right, in the sense that it may be restricted when disclosure to the patient is necessary in order to avoid a risk of serious harm to third persons.

[1]  S. Greene,et al.  Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus , 1997, The Lancet.

[2]  Johannes J. M. van Delden,et al.  Reflective Equilibrium as a Normative-Empirical Model in Bioethics , 1998 .

[3]  C. Pedersen,et al.  A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia. , 1999, Clinical therapeutics.

[4]  P. Tugwell,et al.  Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. , 2000, Rheumatology.

[5]  P. Giral,et al.  Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia. CREOLE Study Team. , 1999, Journal of clinical epidemiology.

[6]  M. Gibbons Choice and Responsibility: Innovation in a New Context , 2005 .

[7]  J. Fletcher,et al.  Privacy and disclosure in medical genetics examined in an ethics of care. , 1991, Bioethics.

[8]  J. Donovan,et al.  Patient Decision Making: The Missing Ingredient in Compliance Research , 1995, International Journal of Technology Assessment in Health Care.

[9]  H. Ten Have,et al.  Geneticization: the Cyprus paradigm. , 1998, The Journal of medicine and philosophy.

[10]  M. Flaten,et al.  Drug-related information generates placebo and nocebo responses that modify the drug response. , 1999, Psychosomatic medicine.

[11]  R. A. Sears THE RIGHT NOT TO KNOW. , 1965, South Dakota journal of medicine.

[12]  L. Doyal Closing the gap between professional teaching and practice , 2001, BMJ : British Medical Journal.

[13]  G. Hottois A philosophical and critical analysis of the European convention of bioethics. , 2000, The Journal of medicine and philosophy.

[14]  J L Bootman,et al.  Drug-related morbidity and mortality. A cost-of-illness model. , 1995, Archives of internal medicine.

[15]  W. Haefeli,et al.  [Conviction as a basis for compliance and strategies for improving compliance]. , 1999, Schweizerische medizinische Wochenschrift.

[16]  J. Rawls,et al.  A Theory of Justice , 1971, Princeton Readings in Political Thought.

[17]  L. Forrow,et al.  Deciding for others: The ethics of surrogate decision‐making , 1990 .

[18]  J Singer,et al.  The consent form as a possible cause of side effects , 1987, Clinical pharmacology and therapeutics.

[19]  R. Hayward,et al.  Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer. , 2001, JAMA.

[20]  A. Clarke The genetic testing of children. , 1995, Journal of medical genetics.

[21]  D. Malone,et al.  The Relationship between Drug Therapy Noncompliance and Patient Characteristics, Health‐Related Quality of Life, and Health Care Costs , 2000, Pharmacotherapy.

[22]  S. Maffettone,et al.  Political liberalism , 2004 .

[23]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[24]  J. Oakley Democracy, embryonic stem cell research, and the Roman Catholic church , 2002, Journal of medical ethics.

[25]  Stephanie L. Anderson GENETIC PRIVACY: A CHALLENGE TO MEDICO-LEGAL NORMS , 2004, The Journal of legal medicine.

[26]  V. English,et al.  Genetic privacy: orthodoxy or oxymoron? , 1999, Journal of medical ethics.

[27]  V. K. Bajaj,et al.  Background noise in healthy volunteers--a consideration in adverse drug reaction studies. , 1992, Indian journal of physiology and pharmacology.

[28]  C. Pope,et al.  The ethics of intimate examinations-teaching tomorrow's doctors. , 2003, BMJ : British Medical Journal.

[29]  D. Haslett,et al.  What is Wrong with Reflective Equilibria , 1987 .

[30]  G. Laurie In defence of ignorance: genetic information and the right not to know. , 1999, European journal of health law.

[31]  G. Laurie,et al.  Protecting and promoting privacy in an uncertain world: further defences of ignorance and the right not to know. , 2000, European journal of health law.

[32]  R. Chadwick,et al.  Book Reviews-The Right to Know and the Right Not to Know , 1997 .

[33]  O. O’neill,et al.  Some limits of informed consent , 2003, Journal of medical ethics.

[34]  K. Keywood,et al.  Ignorance, Information and Autonomy , 2001, Theoretical medicine and bioethics.

[35]  N. Col,et al.  The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. , 1990, Archives of internal medicine.

[36]  D A Hussar,et al.  Detection methods and strategies for improving medication compliance. , 1991, American journal of hospital pharmacy.

[37]  L. Foss Thirteen Ways of Looking at a Blackbird , 1980 .

[38]  M. Tohen,et al.  The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. , 1999, The Journal of clinical psychiatry.

[39]  Knowledge of the legislation governing proxy consent to treatment and research , 2003, Journal of medical ethics.

[40]  G. Gillett,et al.  The bioethical structure of a human being. , 2003, Journal of applied philosophy.

[41]  P D Cleary,et al.  What do patients value in their hospital care? An empirical perspective on autonomy centred bioethics , 2003, Journal of medical ethics.

[42]  M. Ibrahim,et al.  Medication noncompliance--a thriving problem. , 1999, The Medical journal of Malaysia.

[43]  N. Swerdlow,et al.  Copernican revolution , 1975, Nature.

[44]  M. Bottis Comment on a view favoring ignorance of genetic information: confidentiality, autonomy, beneficence and the right not to know. , 2000, European journal of health law.

[45]  Graeme T. Laurie CHALLENGING MEDICAL-LEGAL NORMS: THE ROLE OF AUTONOMY, CONFIDENTIALITY, AND PRIVACY IN PROTECTING INDIVIDUAL AND FAMILIAL GROUP RIGHTS IN GENETIC INFORMATION , 2001, The Journal of legal medicine.

[46]  L. Skene,et al.  The role of the church in developing the law , 2002, Journal of medical ethics.

[47]  A. Barsky,et al.  Nonspecific medication side effects and the nocebo phenomenon. , 2002, JAMA.

[48]  R H Brook,et al.  The public release of performance data: what do we expect to gain? A review of the evidence. , 2000, JAMA.